91 related articles for article (PubMed ID: 26063860)
21. A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA?
Orendi JM; Monnery DJ; Manzoor S; Hawkey PM
J Hosp Infect; 2012 Jan; 80(1):82-4. PubMed ID: 22104474
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.
Goldenberg SD; Gumban M; Hall A; Patel A; French GL
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):417-9. PubMed ID: 21683272
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.
Beaulieu C; Dionne LL; Julien AS; Longtin Y
Clin Microbiol Infect; 2014 Oct; 20(10):1067-73. PubMed ID: 24813402
[TBL] [Abstract][Full Text] [Related]
24. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease.
Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
26. A new rapid method for Clostridium difficile DNA extraction and detection in stool: toward point-of-care diagnostic testing.
Freifeld AG; Simonsen KA; Booth CS; Zhao X; Whitney SE; Karre T; Iwen PC; Viljoen HJ
J Mol Diagn; 2012; 14(3):274-9. PubMed ID: 22402170
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile PCR Ribotype 027 Emerges in Taiwan.
Liao TL; Lin CF; Chiou CS; Shen GH; Wang J
Jpn J Infect Dis; 2015; 68(4):338-40. PubMed ID: 25672348
[TBL] [Abstract][Full Text] [Related]
28. Comparison of GeneXpert PCR to BD GeneOhm for detecting C. difficile toxin gene in GDH positive toxin negative samples.
Agaronov M; Karak SG; Maldonado Y; Tetreault J; Aslanzadeh J
Ann Clin Lab Sci; 2012; 42(4):397-400. PubMed ID: 23090736
[TBL] [Abstract][Full Text] [Related]
29. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
[TBL] [Abstract][Full Text] [Related]
30. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
[TBL] [Abstract][Full Text] [Related]
31. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.
Wilcox MH
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():13-20. PubMed ID: 23121550
[TBL] [Abstract][Full Text] [Related]
32. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
Longtin Y; Trottier S; Brochu G; Paquet-Bolduc B; Garenc C; Loungnarath V; Beaulieu C; Goulet D; Longtin J
Clin Infect Dis; 2013 Jan; 56(1):67-73. PubMed ID: 23011147
[TBL] [Abstract][Full Text] [Related]
33. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel.
Peterson LR; Mehta MS; Patel PA; Hacek DM; Harazin M; Nagwekar PP; Thomson RB; Robicsek A
Am J Clin Pathol; 2011 Sep; 136(3):372-80. PubMed ID: 21846912
[TBL] [Abstract][Full Text] [Related]
34. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections.
Hernández-Rocha C; Barra-Carrasco J; Álvarez-Lobos M; Paredes-Sabja D; Guzmán-Durán AM
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):361-5. PubMed ID: 23415540
[TBL] [Abstract][Full Text] [Related]
35. Observing effectiveness of pathology ordering controls in emergency departments.
Wagholikar A; O'Dwyer J; Hansen D; Chu K
Stud Health Technol Inform; 2011; 168():172-8. PubMed ID: 21893926
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection.
Vasoo S; Stevens J; Portillo L; Barza R; Schejbal D; Wu MM; Chancey C; Singh K
J Microbiol Immunol Infect; 2014 Feb; 47(1):75-8. PubMed ID: 22921803
[TBL] [Abstract][Full Text] [Related]
37. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays.
Selvaraju SB; Gripka M; Estes K; Nguyen A; Jackson MA; Selvarangan R
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):224-9. PubMed ID: 21899975
[TBL] [Abstract][Full Text] [Related]
38. Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.
Nikolic D; Richter SS; Asamoto K; Wyllie R; Tuttle R; Procop GW
J Clin Microbiol; 2017 Dec; 55(12):3350-3354. PubMed ID: 28954902
[TBL] [Abstract][Full Text] [Related]
39. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.
Chandra S; Thapa R; Marur S; Jani N
J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178
[TBL] [Abstract][Full Text] [Related]
40. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
